On May 2, 2023, Nicole Steinmetz, Ph.D., advised the board of directors of Mosaic ImmunoEngineering, Inc. of her intention to resign as a member of the board of directors and acting Chief Scientific Officer effective immediately. Dr. Steinmetz confirmed to the Company's board of directors that her resignation is not due to a disagreement with the Company on any matter relating to the Company's operations, policies or practices. Dr. Steinmetz will remain engaged with the Company as a scientific advisor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 USD | +5.50% | -33.33% | -33.33% |
1st Jan change | Capi. | |
---|---|---|
-33.33% | 2.9M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+41.98% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- CPMV Stock
- News Mosaic ImmunoEngineering, Inc.
- Mosaic Immunoengineering, Inc. Announces Nicole Steinmetz, Ph.D., to Resign as A Member of the Board of Directors and Acting Chief Scientific Officer